How can Exponent help you evaluate the safety and performance of pharmaceutical products?
Whether you seek help with developing a new drug-eluting polymer stent technology, establishing validated quality control methods for drug impurities, investigating new hydrogel technologies, or testing the emulsion and dispersion properties of a newly developed medicine, Exponent's multidisciplinary approach provides breakthrough answers for your toughest challenges.
Our chemists, polymer scientists, and chemical engineers assist pharmaceutical manufacturers and medical product developers throughout all stages of the product lifecycle — from early-stage product development and testing services to manufacturing support, facility inspections, delivery, compliance, and product recalls.
Multidisciplinary expertise to assist you throughout the entire product lifecycle.
We help our clients source and test materials, manage chemistry, manufacturing, and controls (CMC) issues, validate material composition, evaluate chemical stability and degradation mechanisms, and investigate product failures such as contamination or non-uniformity.
Our wide range of expertise in chemistry, CMC, and macromolecular science provides technical expertise related to drug substances and drug products across a wide range of dosage forms. We leverage our experience across disciplines such as organic chemistry, inorganic chemistry, surface and polymer science, and manufacturing systems to support medical innovators with their pharmaceutical, combination device, and diagnostics products.
Capabilities
We focus on innovative, multidisciplinary solutions for materials, processes, and products starting at the molecular level, and apply our core competencies in chemistry, polymer science, and materials engineering to support all sizes and scopes of medical innovation.
Experts
Our global and comprehensive expertise across industries gives us a deep understanding of current challenges, best industry practices, and the implications of emerging technologies.
![Jessica Vargas, Ph.D.](/sites/default/files/styles/people/public/media/images/jessica-vargas-689-uuid-669b413fb1f88.png?itok=uRNWurqj)
![Sarah Parker, Ph.D.](/sites/default/files/styles/people/public/media/images/sarah-parker-515-uuid-669b401fe59b8.png?itok=DXcdVbCx)
![Naomi Clayman, Ph.D.](/sites/default/files/styles/people/public/media/images/naomi-clayman-1062-uuid-669b42dd21ad5.png?itok=i6ix4cri)
![Chris Lyons, Ph.D.](/sites/default/files/styles/people/public/media/images/chris-lyons-407-uuid-669b3f7aac129.png?itok=fw8weKdb)
![Abigail Oelker, Ph.D.](/sites/default/files/styles/people/public/media/images/abigail-oelker-493-uuid-669b3ffc0f4b1.png?itok=opzZLwPP)
![Benjamin Streifel, Ph.D.](/sites/default/files/styles/people/public/media/images/benjamin-streifel-867-uuid-66a4156bbc669.png?itok=XCxbNv4a)